Peptide record

TPDB01143

ACE inhibitor ACE inhibitors Antioxidant standard
4 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB01143
ACE inhibitor
ACE inhibitors Antioxidant
Cardiometabolic peptides Functional / health-promoting peptides
Peptipedia AnOxPePred - 1.0 AODB Multi-AOP
standard
No
A 4-aa standard-residue multi-activity (ACE inhibitors and Antioxidant) peptide sequence curated from Peptipedia, AnOxPePred - 1.0, AODB, and other sources, with an available 3D structural model.
Sequence
LPYY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C29H38N4O7
ARNDCEQGHIKMFSTWV
Y
554.64
5.88
0
0
3
-0
-1.16
-0.100
97.50
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
2980
5.37
2
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
0
K
0
M
0
F
1
P
0
S
0
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 2 V: 0
Chemical Descriptors
4 reviewed residue count
C29H38N4O7 sequence-only estimate (linear, free termini)
554.64 sequence-only estimate (linear, free termini)
5.88 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-1.16 sequence-only estimate (linear, free termini)
-0.100 sequence-only estimate (linear, free termini)
554.6331 Activity
554.2731 Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
116.26 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Li J., Su J., Chen M., Chen J., Ding W., Li Y., Yin H.
Two novel potent ACEI peptides isolated from Pinctada fucata meat hydrolysates using in silico analysis: identification, screening and inhibitory mechanisms. RSC Adv., 11, 12172-12182, 2021
2021
Journal

Other

4
BIOPEP-UWM database of bioactive peptides SMILES: [C@H](N)(CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(O)=O InChI=1S/C29H38N4O7/c1-17(2)14-22(30)28(38)33-13-3-4-25(33)27(37)31-23(15-18-5-9-20(34)10-6-18)26(36)32-24(29(39)40)16-19-7-11-21(35)12-8-19/h5-12,17,22-25,34-35H,3-4,13-16,30H2,1-2H3,(H,31,37)(H,32,36)(H,39,40)/t22-,23-,24-,25-/m0/s1 InChIKey=FZHFSHYCWQZWFU-QORCZRPOSA-N Antioxidative peptide according to the BIOPEP-UWM database of bioactive peptides (ID 3309)
Evidence 2 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

AODB
DFBP
Additional Detail Fields 1 fields
4